The Impact of Initial Tumor Response on Survival Outcomes of Patients with HER2-positive Advanced Breast Cancer Treated with Docetaxel, Trastuzumab, and Pertuzumab: an Exploratory Analysis of the CLEOPATRA Trial.
Clinical Breast Cancer（2024）
Key words
Complete response,HER2-positive breast cancer,Imaging
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined